Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant human C1-inhibitor

EU orphan designation number: EU/3/01/036
Active ingredient: Recombinant human C1-inhibitor
Indication: Treatment of angioedema caused by C1 inhibitor deficiency
Sponsor: Pharming Group N.V.
Archimedesweg 4, 2333 CN Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/05/2001 Orphan designation EMEA/OD/053/00 (2001)1199 of 11/05/2001
02/12/2002 Transfer of orphan designation EMEA/OD/053/00/T/01 (2002)4753 of 29/11/2002
17/09/2010 Removal of orphan designation from Community Register